MCII + MOVE! Program for Weight Management
(WOOP VA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help Veterans manage their weight through a program called MOVE!, delivered over the phone. Researchers are testing whether adding a technique called WOOP (Wish, Outcome, Obstacle, Plan) can improve motivation and weight loss results. Participants will receive either the standard MOVE! program or the enhanced version with WOOP. Veterans with a BMI of 30 or higher, or a BMI of 25 with an obesity-related condition like diabetes or heart disease, who wish to lose weight and can attend visits in Manhattan, may be eligible.
As an unphased trial, this study offers Veterans a unique opportunity to explore innovative weight management strategies.
Do I have to stop taking my current medications to join the trial?
The trial requires that you do not take any FDA-approved weight loss medications or certain diabetes drugs in the GLP-1 agonists class. If you are on these medications, you would need to stop taking them to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In a previous study, the Mental Contrasting with Implementation Intentions (MCII) strategy, which includes the WOOP technique (Wish, Outcome, Obstacle, Plan), proved to be safe and well-tolerated. Research over 20 years shows that MCII effectively boosts motivation for behavior change without harmful side effects. This strategy has been used successfully in various settings, including weight management programs like the VA's MOVE! program.
The MOVE! program is a well-established weight management strategy designed specifically for Veterans. It has been widely used and is generally considered safe. Combining MCII with MOVE! aims to improve motivation and results without introducing new safety concerns.
Overall, both the MCII technique and the MOVE! program have strong safety records based on existing research. Participants in clinical settings have not reported significant negative effects, indicating that the treatment is well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about the MCII + MOVE! Program for Weight Management trial because it explores a novel approach to weight management by integrating mental contrasting with implementation intentions (WOOP) with the existing MOVE!/TeleMOVE! program. Unlike traditional weight management programs that focus primarily on diet and physical activity, this experimental arm introduces a psychological technique that helps individuals visualize their goals and develop concrete plans to overcome obstacles. By combining mental strategies with physical health education, the study aims to enhance the effectiveness of weight management efforts, potentially offering a more comprehensive solution for individuals struggling with weight issues.
What evidence suggests that this trial's treatments could be effective for weight management?
Research has shown that the MOVE! program, a treatment arm in this trial, helps people lose weight and change their habits. Studies have found that programs like MOVE!, which focus on lifestyle changes, can lead to a weight loss of 5% or more. Another treatment arm in this trial combines the MOVE! program with the MCII technique, also known as WOOP (Wish, Outcome, Obstacle, Plan). Developed over 20 years, MCII helps people stay motivated to change their behavior. Early results suggest that MCII can boost motivation through mental imagery, potentially enhancing the effectiveness of the MOVE! program. Together, these methods aim to help Veterans lose weight and improve their health.13678
Who Is on the Research Team?
Melanie R. Jay, MD MS
Principal Investigator
VA NY Harbor Healthcare System, New York, NY
Are You a Good Fit for This Trial?
This trial is for Veterans aged 18-70 with obesity or related conditions, willing to join the MOVE! program and able to attend evaluations in Manhattan VA. They must have had a primary care visit within the past year, desire weight loss, and be reachable by phone. Excluded are those seeing dietitians frequently, recently hospitalized, involved in other weight studies or taking certain weight loss drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Visit
Participants receive baseline assessments and are randomized into trial arms
Treatment
Participants receive either MCII + MOVE!/TeleMOVE! or MOVE!/TeleMOVE! alone
Follow-up
Participants are monitored for weight, diet, and physical activity changes
What Are the Treatments Tested in This Trial?
Interventions
- Information About Diet, Physical Activity, and Weight Management
- mental contrasting with implementation intentions
- telephone-delivered MOVE!
- Telephone MCII Check-ins
telephone-delivered MOVE! is already approved in United States for the following indications:
- Weight management
- Obesity
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
New York University
Collaborator